Proteomic Analysis of Blood Proteins in Patients Undergoing Albumin Dialysis
Author Information
Author(s): Gay Marina, Pares Albert, Carrascal Montserrat, Bosch-i-Crespo Pau, Gorga Marina, Mas Antoni, Abian Joaquin
Primary Institution: CSIC/UAB Proteomics Laboratory, Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas/Institut d'investigacions Biomèdiques August Pi i Sunyer (IIBB-CSIC/IDIBAPS), Bellaterra, Spain
Hypothesis
The study aims to characterize the peptides and proteins captured by the MARS system from patients' blood during albumin dialysis.
Conclusion
The study identified over 1,500 peptide sequences corresponding to 144 proteins, including several that may have therapeutic or adverse effects related to albumin dialysis.
Supporting Evidence
- Over 1,500 peptide sequences corresponding to 144 proteins were identified.
- Five proteins were confirmed to be removed by the dialysis procedure using targeted selected-reaction monitoring MS/MS.
- SLURP1 levels were significantly higher in cholestatic patients than in controls.
Takeaway
Doctors used a special machine to clean blood from patients with liver problems, and they found many proteins that could help understand how the treatment works.
Methodology
The study used a shotgun proteomic approach combined with targeted mass spectrometry to analyze proteins captured by the MARS system.
Limitations
The study's findings may be limited by the complexity of the albumin matrix and the low concentration of some proteins.
Participant Demographics
Patients included four with cholestasis and resistant pruritus and one with Wilson's disease.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website